reaching the normal or near-normal range in 84% of patients by the sixth month of the trial83,84. OXLUMO® was approved by both FDA and EMA in 2020 for the treatment of PH185. Recently, the results of two phase 3 studies evaluating OXLUMO® efficacy in a cohort of children under 6...
Not intended to substitute for usual standard-of-care rehabilitation regimens.Spasticity Associated with Cerebral Palsy in Pediatric PatientsHas been used for the management of upper-extremity deformities associated with cerebral palsy in pediatric patients† (e.g., shoulder internal rotation and/or ...
Despite personal use being stable or reduced, participants still contended with several adverse events related to drug use, including personal or witnessed overdose, impaired health, decreased access to inpatient rehabilitation services, and impaired relationships. Some harm reduction strategies, such as ...
In the past 20 years, it has been difficult to improve the quality of prescriptions due to the internal organization of nursing homes in France. Each resident is free to choose a general practitioner (GP), who may or may not have their practice in or near the location of a nursing home...
experimental group, nasal irrigation with budesonide and physiological saline was administered twice a day for 30 days, in addition to olfactory rehabilitation, in the morning and in the evening. In the control group, only nasal irrigation with physiological saline was administered, morning and ...